Granules India posts Q1 FY25 consolidated PAT higher at Rs. 134.64 Cr
Granules India has reported total income of Rs. 1181.92 crores during the period ended June 30, 2024
Granules India has reported total income of Rs. 1181.92 crores during the period ended June 30, 2024
Finance Minister Nirmala Sitharaman is set to present the full budget for the current financial year on July 23
This facility manufactures APIs & formulations of oncology and non-oncology products.
Granules India has reported total income of Rs. 1156.23 crores during the period ended December 31, 2023
Sales in the US region grew well, partially offset by the decline in the LATAM and European regions
API, PFI, and Finished dosages contribute 30%, 15%, and 55% of revenue from operations respectively for Q1FY24
The zero-observation outcome reflects the company's robust quality management systems and commitment to excellence in its operations.
Granules India sponsored an initiative to ignite a drug-free revolution and contribute towards an empowered society
The facility is over 79,000 square feet and is equipped with packaging lines
The audit is a pre-approval inspection for three products filed from the facility
        Subscribe To Our Newsletter & Stay Updated